您当前所在的位置:首页 > 产品中心 > 产品信息
Ketamine_分子结构_CAS_6740-88-1)
点击图片或这里关闭

Ketamine

产品号 DB01221 公司名称 DrugBank
CAS号 6740-88-1 公司网站 http://www.ualberta.ca/
分子式 C13H16ClNO 电 话 (780) 492-3111
分子量 237.72524 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 1091

产品价格信息

请登录

产品别名

标题
Ketamine
IUPAC标准名
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
IUPAC传统名
(+-)-ketamine
商标名
Ketaject
Ketalar
CLSTA 20
Esketamine
Ketalar base
Ketanest
Ketolar
别名
Ketamine Base
CI 581 base
(-)-Ketamine
(S)-(-)-Ketamine
(S)-Ketamine
Ketamine HCL
l-Ketamine

产品登记号

CAS号 6740-88-1
PubChem SID 46508295
PubChem CID 3821

产品性质

疏水性(logP) 2.9

产品详细信息

详细说明 (English)
Item Information
Drug Groups approved
Description A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (receptors, N-methyl-D-aspartate) and may interact with sigma receptors. [PubChem]
Indication For use as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation.
Pharmacology Ketamine is a rapid-acting general anesthetic producing an anesthetic state characterized by profound analgesia, normal pharyngeal-laryngeal reflexes, normal or slightly enhanced skeletal muscle tone, cardiovascular and respiratory stimulation, and occasionally a transient and minimal respiratory depression. Ketamine is indicated as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. The anesthetic state produced by Ketamine has been termed “dissociative anesthesia” in that it appears to selectively interrupt association pathways of the brain before producing somesthetic sensory blockade. It may selectively depress the thalamoneocortical system before significantly obtunding the more ancient cerebral centers and pathways (reticularactivating and limbic systems).
Affected Organisms
Humans and other mammals
Biotransformation Hepatic.
Absorption Rapidly absorbed following parenteral administration.
Half Life 2.5-3 hours.
References
Harrison NL, Simmonds MA: Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br J Pharmacol. 1985 Feb;84(2):381-91. [Pubmed]
Bergman SA: Ketamine: review of its pharmacology and its use in pediatric anesthesia. Anesth Prog. 1999 Winter;46(1):10-20. [Pubmed]
Bonanno FG: Ketamine in war/tropical surgery (a final tribute to the racemic mixture). Injury. 2002 May;33(4):323-7. [Pubmed]
Lankenau SE, Sanders B, Bloom JJ, Hathazi D, Alarcon E, Tortu S, Clatts MC: First injection of ketamine among young injection drug users (IDUs) in three U.S. cities. Drug Alcohol Depend. 2007 Mar 16;87(2-3):183-93. Epub 2006 Sep 18. [Pubmed]
Reboso Morales JA, Gonzalez Miranda F: [Ketamine] Rev Esp Anestesiol Reanim. 1999 Mar;46(3):111-22. [Pubmed]
External Links
Wikipedia
RxList
Drugs.com

参考文献

  • Harrison NL, Simmonds MA: Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br J Pharmacol. 1985 Feb;84(2):381-91. Pubmed
  • Bergman SA: Ketamine: review of its pharmacology and its use in pediatric anesthesia. Anesth Prog. 1999 Winter;46(1):10-20. Pubmed
  • Bonanno FG: Ketamine in war/tropical surgery (a final tribute to the racemic mixture). Injury. 2002 May;33(4):323-7. Pubmed
  • Lankenau SE, Sanders B, Bloom JJ, Hathazi D, Alarcon E, Tortu S, Clatts MC: First injection of ketamine among young injection drug users (IDUs) in three U.S. cities. Drug Alcohol Depend. 2007 Mar 16;87(2-3):183-93. Epub 2006 Sep 18. Pubmed
  • Reboso Morales JA, Gonzalez Miranda F: [Ketamine] Rev Esp Anestesiol Reanim. 1999 Mar;46(3):111-22. Pubmed